Praxis Precision Medicines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRAX and other ETFs, options, and stocks.About PRAX
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus.
CEOMarcio Souza
CEOMarcio Souza
Employees116
Employees116
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2015
Founded2015
Employees116
Employees116
PRAX Key Statistics
Market cap4.66B
Market cap4.66B
Price-Earnings ratio-14.45
Price-Earnings ratio-14.45
Dividend yield—
Dividend yield—
Average volume769.42K
Average volume769.42K
High today$197.55
High today$197.55
Low today$176.99
Low today$176.99
Open price$178.20
Open price$178.20
Volume860.18K
Volume860.18K
52 Week high$206.71
52 Week high$206.71
52 Week low$26.70
52 Week low$26.70
Stock Snapshot
As of today, Praxis Precision Medicines(PRAX) shares are valued at $186.42. The company's market cap stands at 4.66B, with a P/E ratio of -14.45.
On 2025-11-15, Praxis Precision Medicines(PRAX) stock moved within a range of $176.99 to $197.55. With shares now at $186.42, the stock is trading +5.3% above its intraday low and -5.6% below the session's peak.
Trading activity shows a volume of 860.18K, compared to an average daily volume of 769.42K.
Over the past 52 weeks, Praxis Precision Medicines(PRAX) stock has traded between a high of $206.71 and a low of $26.70.
Over the past 52 weeks, Praxis Precision Medicines(PRAX) stock has traded between a high of $206.71 and a low of $26.70.
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
0%
Sell
7.1%
People also own
Based on the portfolios of people who own PRAX. This list is generated using Robinhood data, and it’s not a recommendation.